IT TAKES a special type of person to stay the course as a whistleblower. Dismissal from employment, vilification and isolation are just a few of the prices to pay. But Brook Jackson, the clinical trial regional director who has been battling against Pfizer since 2020 to bring facts to light, is not bowing to intimidation.
